- Home
- NRXP vs STEX Comparison
NRXP vs STEX Comparison
Compare NRXP & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXP | STEX |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | 29 | 6 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 86.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | STEX |
|---|---|---|
| Price | $3.92 | $0.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $38.25 | $9.00 |
| AVG Volume (30 Days) | 1.7M | ★ 1.7M |
| Earning Date | 05-14-2026 | 05-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | $1,044.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $0.70 |
| 52 Week High | $5.06 | $7.44 |
Technical Indicators
Market Signals| Indicator | NRXP | STEX |
|---|---|---|
| Relative Strength Index (RSI) | 55.17 | 42.48 |
| Support Level | $1.89 | $0.98 |
| Resistance Level | $5.06 | $1.21 |
| Average True Range (ATR) | 0.46 | 0.18 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 48.06 | 10.99 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About STEX Streamex Corp.
Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.